Acumen Wealth Advisors LLC Reduces Holdings in Cigna Group $CI

Acumen Wealth Advisors LLC lowered its position in Cigna Group (NYSE:CI) by 89.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 939 shares of the health services provider’s stock after selling 8,327 shares during the quarter. Acumen Wealth Advisors LLC’s holdings in Cigna Group were worth $259,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Evercore Wealth Management LLC increased its holdings in shares of Cigna Group by 2.8% during the 1st quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock worth $347,000 after buying an additional 35 shares during the last quarter. Cary Street Partners Investment Advisory LLC grew its stake in shares of Cigna Group by 11.0% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock worth $100,000 after purchasing an additional 36 shares in the last quarter. OLD National Bancorp IN lifted its position in Cigna Group by 3.7% in the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock valued at $284,000 after acquiring an additional 37 shares during the last quarter. IHT Wealth Management LLC increased its stake in Cigna Group by 2.5% in the fourth quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock valued at $423,000 after purchasing an additional 38 shares during the period. Finally, Whetstone Capital Advisors LLC boosted its stake in shares of Cigna Group by 4.9% during the fourth quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock worth $228,000 after buying an additional 39 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

CI has been the topic of a number of research analyst reports. Wells Fargo & Company boosted their target price on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Piper Sandler decreased their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a report on Wednesday, June 3rd. The Goldman Sachs Group increased their price target on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a report on Monday, May 4th. Wall Street Zen downgraded Cigna Group from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Finally, Sanford C. Bernstein upped their target price on Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $339.45.

Cigna Group Trading Up 1.5%

Shares of Cigna Group stock opened at $282.24 on Friday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The company’s fifty day simple moving average is $286.02 and its 200-day simple moving average is $281.28. The company has a market cap of $74.58 billion, a price-to-earnings ratio of 11.68, a PEG ratio of 0.96 and a beta of 0.29. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. During the same quarter in the previous year, the firm posted $7.20 earnings per share. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts expect that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Insider Transactions at Cigna Group

In related news, insider Nicole S. Jones sold 19,436 shares of Cigna Group stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is currently owned by insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.